Highlights
NASDAQ: VTGN       Vistagen Therap. Com
Last Price Today's Change   Day's Range   Trading Volume
0.812   +0.016 (2.01%)  0.785 - 0.87  6,255,500

Overview

 
Avg Volume (4 weeks):3,222,785
4 Weeks Range:0.46 - 1.00
4 Weeks Price Volatility (%):
65.19%
52 Weeks Range:0.29 - 1.49
52 Weeks Price Volatility (%):
43.50%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

VistaGen Therapeutics Inc is a biotechnology firm. The company is in its clinical stage and engaged in developing and commercializing product candidates for patients with diseases and disorders involving the central nervous system. Its lead product candidate, AV-101, is an orally available prodrug candidate in Phase II development, initially for the adjunctive treatment of a major depressive disorder in patients with an inadequate response to standard antidepressants.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

4293  3944  539  176 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 BIOC 1.14+0.246 
 AAL 13.04+0.48 
 RKT 21.51+3.51 
 SLV 26.88+1.83 
 SQQQ 5.36-0.23 
 CBL 0.254+0.06 
 ADTX 7.60+3.67 
 CCL 13.78-0.24 
 MARA 5.09+0.89 
 PLUG 10.73+1.40 
Partners & Brokers